Name | Number of supported studies | Average coverage | |
---|---|---|---|
melanocyte | 7 studies | 65% ± 30% |
Insufficient scRNA-seq data for expression of DCT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 73% | 3118.17 | 1318 / 1809 | 91% | 575.59 | 431 / 472 |
brain | 92% | 170.18 | 2440 / 2642 | 71% | 2.81 | 502 / 705 |
adrenal gland | 88% | 109.13 | 228 / 258 | 6% | 0.09 | 14 / 230 |
ovary | 91% | 105.26 | 163 / 180 | 2% | 0.03 | 8 / 430 |
prostate | 77% | 91.06 | 188 / 245 | 2% | 0.03 | 9 / 502 |
eye | 0% | 0 | 0 / 0 | 71% | 12.73 | 57 / 80 |
uterus | 69% | 77.55 | 117 / 170 | 2% | 0.06 | 10 / 459 |
blood vessel | 71% | 71.82 | 947 / 1335 | 0% | 0 | 0 / 0 |
thymus | 66% | 60.02 | 433 / 653 | 2% | 0.03 | 14 / 605 |
pancreas | 66% | 54.51 | 216 / 328 | 0% | 0 | 0 / 178 |
intestine | 55% | 60.95 | 536 / 966 | 3% | 0.16 | 17 / 527 |
bladder | 57% | 53.86 | 12 / 21 | 1% | 0.02 | 6 / 504 |
breast | 53% | 91.75 | 241 / 459 | 3% | 0.14 | 30 / 1118 |
esophagus | 52% | 57.30 | 757 / 1445 | 1% | 0.05 | 2 / 183 |
adipose | 50% | 45.36 | 600 / 1204 | 0% | 0 | 0 / 0 |
muscle | 45% | 33.17 | 364 / 803 | 0% | 0 | 0 / 0 |
kidney | 27% | 18.43 | 24 / 89 | 10% | 0.24 | 89 / 901 |
lung | 31% | 22.07 | 182 / 578 | 1% | 0.02 | 13 / 1155 |
stomach | 24% | 25.81 | 85 / 359 | 5% | 0.15 | 13 / 286 |
liver | 24% | 17.58 | 54 / 226 | 1% | 0.04 | 6 / 406 |
heart | 20% | 13.59 | 170 / 861 | 0% | 0 | 0 / 0 |
spleen | 20% | 10.83 | 47 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
peripheral blood | 1% | 0.25 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0021847 | Biological process | ventricular zone neuroblast division |
GO_0048066 | Biological process | developmental pigmentation |
GO_0009637 | Biological process | response to blue light |
GO_0008544 | Biological process | epidermis development |
GO_0006583 | Biological process | melanin biosynthetic process from tyrosine |
GO_0048468 | Biological process | cell development |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042470 | Cellular component | melanosome |
GO_0033162 | Cellular component | melanosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004167 | Molecular function | dopachrome isomerase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DCT |
Protein name | DCT L-dopachrome tautomerase (DCT) (DT) (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2) L-dopachrome tautomerase (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) |
Synonyms | TYRP2 |
Description | FUNCTION: Plays a role in melanin biosynthesis . Catalyzes the conversion of L-dopachrome into 5,6-dihydroxyindole-2-carboxylic acid (DHICA). . |
Accessions | ENST00000377028.10 [P40126-1] ENST00000483392.6 ENST00000446125.1 [P40126-2] P40126 Q0PK43 A0A0A0MTD3 |